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ABSTRACT
Background Little is currently known about the
effects of the coronavirus (COVID-19) pandemic on
neurointerventional (NI) procedural volumes or its toll on
physician wellness.
Methods A 37-question online survey was designed
and distributed to physician members of three NI
physician organizations.
Results A total of 151 individual survey responses were
obtained. Reduced mechanical thrombectomy procedures
compared with pre-pandemic were observed with 32%
reporting a greater than 50% reduction in thrombectomy
volumes. In concert with most (76%) reporting at least a
25% reduction in non-mechanical thrombectomy urgent
NI procedures and a nearly unanimous (96%) cessation
of non-urgent elective cases, 68% of physicians
reported dramatic reductions (>50%) in overall NI
procedural volume compared with pre-pandemic.
Increased door-to-puncture times were reported by
79%. COVID-19-positive infections occurred in 1% of
physician respondents: an additional 8% quarantined
for suspected infection. Sixty-six percent of respondents
reported increased career stress, 56% increased personal
life/family stress, and 35% increased career burnout.
Stress was significantly increased in physicians with
COVID-positive family members (P<0.05).
Conclusions This is the first study designed to
understand the effects of the COVID-19 pandemic on
NI physician practices, case volumes, compensation,
personal/family stresses, and work-related burnout.
Future studies examining these factors following the
resumption of elective cases and relaxing of social
distancing measures will be necessary to better
understand these phenomena.

INTRODUCTION
© Author(s) (or their
employer(s)) 2020. No
commercial re-use. See rights
and permissions. Published
by BMJ.
To cite: Fargen KM, Leslie-
Mazwi TM, Klucznik RP, et al.
J NeuroIntervent Surg
2020;12:927–931.

The zoonotic novel β-coronavirus was identified
in the human population in late 2019 and subsequently spread rapidly from Asia across the world.
Labeled as the Coronavirus Disease 2019 (COVID19) by the WHO, infection induced by the virus
reached pandemic proportions by early March
2020. By mid-
March, most US hospitals transitioned into an emergency mode with cessation
of all elective, non-
urgent procedures and clinic
visits, as requested by the US Surgeon General1 and

supported by recommendations from major physician organizations.2 To minimize exposure to physicians and staff, the Society of Neurointerventional
Surgery (SNIS)3 and others4–6 provided recommendations for the continued care of patients requiring
emergency neurointerventional procedures.
Across the US, there has been widespread disruption to normal clinical practice. Anecdotally, many
centers have noticed reductions in case volumes for
emergency procedures during the pandemic. Little
is currently known about the effects of COVID-19
on neurointerventional procedural volumes, availability of personal protective equipment (PPE),
physician or team member COVID-19 infections
or exposures, and the personal or professional toll
of the pandemic on physician wellness or burnout.
This survey represents a multi-
society combined
effort, including support from SNIS, the Society
of Vascular and Interventional Neurology (SVIN),
and the American Association of Neurological
Surgeons/Congress of Neurological Surgeons
Combined Cerebrovascular Section (CV Section),
to better understand these effects.

METHODS

Institutional review board approval was obtained
prior to study initiation. An informal survey writing
group committee of six members, with representatives of each of the three specialties that contribute
directly to neurovascular care, assembled the survey.
The writing group was tasked with composing
a concise set of queries to explore the effect of
COVID-19 on neurointerventional practices while
addressing pertinent practice and demographic
factors. The writing group finalized a 37-question
online survey designed with a completion time
of approximately 5 min to optimize response
rate (online supplementary materials). This was
prepared through SurveyMonkey. Leaders of the
SNIS, SVIN, and CV Section were then asked to
review and contribute their thoughts to the survey.
When the instrument was agreed to, the three societies distributed the survey by email to their respective members soliciting participation completion.
In addition, a copy of the email was posted on the
SNIS Connect website for SNIS members. Communications contained the link to the survey that
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could be easily accessed with a single click. No compensation
was offered to participants. No requests to complete the survey
were placed on public social media platforms. All responses were
anonymous.
The authors, including acting Presidents from all three of these
organizations, estimate a potential sample size of approximately
1,000 NI physicians in the US. SurveyMonkey records the IP
address, therefore limiting respondents to a single response.
Reminder emails were sent periodically during the study period,
which lasted 3 weeks (May 2020).
For many questions, respondents were asked to compare
pandemic conditions (mid-March 2020 through date of survey
completion) to pre-
pandemic conditions (2019 and January–
February 2020). Respondents were asked to self-report whether
they practice in a COVID-19 epicenter, which was, by design,
not clearly defined but instead allowed for individual respondents to report in a subjective manner based on COVID-19 incidence within the surrounding area.
Statistics were performed using IBM SPSS Statistics (v26). Chi-
square tests were performed to assess for statistical comparisons,
using an alpha-level of 0.05 for determination of significance.

RESULTS

A total of 151 individual survey responses were obtained for a
response rate of approximately 15% based on the estimated total
NI physician sample size. Of these, 135 (89%) had no missing
responses.

Respondent personal and practice characteristics

Respondent characteristics based on survey questions are
shown in table 1. Most respondents were male and employed at
academic hospitals in metropolitan areas. Less than half (44%) of
respondents reported their institution in a COVID-19 epicenter.

Case volumes

The effect of COVID-19 on NI case volumes is shown in figure 1.
Sixty-eight percent of respondents indicated that all elective cases
were halted during the preceding months, with 28% reporting
near-complete cessation of elective NI cases except for a few
exceptional elective patients. Only 4% of respondents indicated
that most or all elective NI cases continued during the pandemic.
The majority of respondents (68%) indicated a greater than
25% reduction in mechanical thrombectomy (MT) for emergent
large-vessel occlusion (ELVO) case volumes compared with pre-
pandemic levels (figure 1). In contrast, only 9% of respondents
indicated a higher rate of MT procedures. Similarly, 76% of
respondents indicated more than a 25% reduction in non-MT
urgent NI procedures (ruptured aneurysms, symptomatic carotid
stenting, etc.) compared with pre-pandemic. The vast majority
(93%) reported decreased overall NI case volumes compared
with pre-pandemic.

Table 1

Personal and practice characteristics of respondents

Variable

Number of respondents
(% of total)

Training background
 Radiology

56 (37.1)

 Neurology

41 (27.2)

 Neurosurgery

54 (35.8)

Gender
 Male
 Female

130 (86.1)
21 (13.9)

Practice setting
 Academic with residents/fellows

99 (66.0)

 Academic without residents/fellows

15 (10.0)

 Private

36 (24.0)

Years of independent practice
 Less than 5 years

33 (22.2)

 5–9 years

36 (24.2)

 10–19 years

53 (35.6)

 More than 20 years

27 (18.1)

Hospital location
 Metropolitan area (population >1 million)

83 (55.3)

 Large city (population 500 K-1 million)

31 (20.7)

 Small–medium city (population 50 K-500K)

32 (21.3)

 Rural/community (population <50K)

4 (2.7)

Hospital located in COVID-19 epicenter
 No

77 (55.8)

 Yes

61 (44.2)

reduced aggressiveness in patient selection, the most common
reasons for doing so were to protect staff from COVID-19 exposure (95%) and to protect themselves and their families from
possible exposure (62%). A minority indicated being less aggressive due to insufficient PPE (20%) or as a result of directives
from departmental or institutional leadership (20%).
Only 26% of physicians reported changing anesthesia practices during the pandemic, with 92% of those that altered their

Thrombectomy patient care

Among respondents, only 21% indicated no change in door-
to-puncture times for MT patients. In contrast, 14% reported
an average of 30 min or longer delay, 35% indicated an average
of 10–30 min delays, and 29% reported mild average delays in
door-to-puncture times of 10 min or less. During the pandemic,
two-thirds of respondents (67%) reported no change in their
approach to selecting patients for emergent procedures. Just
over one-quarter of respondents (27%) reported being slightly
less aggressive in selecting patients for treatment, with 4%
reporting being much less aggressive. In those that reported
928

Figure 1 Reported effects of the pandemic on case volumes
compared with pre-pandemic.
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practices converting to general anesthesia from a prior preference
of conscious sedation. Of those respondents with unchanged
practices due to COVID-19, the distribution of anesthesia preference was split evenly among conscious sedation (50%) and
general anesthesia (50%).
The majority of respondents indicated that COVID-19 had
not had a deleterious effect on the quality of care provided to
patients with large-vessel occlusions at their institution (59%),
while marginally, moderately, and severely worsened quality of
care was reported by 29%, 10% and 2%, respectively.

Physician and neurointerventional team exposures

Thirty-eight percent of respondents reported never having examined or performed procedures on a COVID-19-positive patient.
Of the remainder, most (41%) had done so on only one or two
positive patients, with 5% having examined or treated 10 or
more COVID-19-positive patients. The vast majority of respondents reported that PPE was either always adequate (62%) or
adequate most of the time (30%) for the safety of the NI team.
Of all respondents, only two tested positive for COVID-19
(1%; neither were hospitalized) and an additional 8% quarantined but tested negative or quarantined based on symptoms
but were not tested. Only 5% of respondents reported that one
or more NI team members (nurses, technologists, physician
colleagues) were hospitalized due to COVID-19 infection.

Effects of COVID-19 on workplace, call, and compensation

Most respondents (87%) did not have to take additional NI call
outside of the norm during the pandemic, with a very small minority
having to cover additional call due to a quarantined colleague (9%)
or due to colleagues refusing to participate in call (4%). Only 9% of
physicians reported being deployed into a role outside of their usual
practice during the pandemic due to shortages: in contrast, 58%
reported non-physician members of their NI team being deployed
into non-routine roles due to staff shortages.
Nearly half (48%) reported no changes to their compensation or
benefits during the pandemic, while 30% reported a reduction of
25% or less and 23% reported a reduction of greater than 25% of
their normal compensation. Of those that reported reduced compensation, most (56%) considered this reduction fair and justified.
Only 1% of respondents reported their employment position
being terminated or furloughed, with 3% reporting that their
employment position was likely to be terminated or furloughed in
the future.

Personal life and professional burnout

Most physicians did not have to spend time living apart from their
families during the pandemic (82%) and the overwhelming majority
did not have anyone in their immediate family test positive for
COVID-19 (95%). Overall stress related to family life and career
and overall career burnout are displayed in figure 2.

Figure 2 Reported effects of the pandemic on career stress, family
and personal stress, and overall career burnout.

COVID-19 epicenters

Respondents located in epicenters reported significantly higher
COVID-19-
positive patient exposures compared with non-
epicenter respondents (P=0.002). Forty-nine percent of respondents in non-
epicenter locations reported no exposures to
COVID-19-positive patients, compared with only 25% of respondents in epicenters. There was no statistical difference in terms
of need to self-quarantine (P=0.77) or in severely ill NI team
members (P=0.26) based on epicenter status. MT case volume,
non-MT urgent procedural volume, and overall procedural volume
responses did not differ based on epicenter status (P=0.35, 0.29,
and 0.29, respectively). There were no differences in pandemic-
related career burnout (P=0.46), stress related to work (P=0.33),
or stress related to personal/family life (P=0.99) between groups.

Other factors

There was no relationship between hospital location, size,
gender, years of practice, or training background on burnout,
stress related to career, or stress related to personal/family life
(all P>0.05). Having children at home with the need for additional schooling/childcare was unrelated to burnout or stress (all
P>0.05). Those respondents with COVID-19-
positive immediate family members reported significantly increased personal/
family stress (P=0.02) and career stress (P=0.04) compared
with those without infected family members.

DISCUSSION

This is the first study to survey US neurointerventional physicians to understand the effects of the COVID-19 pandemic
on physician practices, case volumes, compensation, personal/
family stresses, and work-related burnout. There are a number
of important and novel findings from this study.
Most respondents reported reduced MT procedures compared
with pre-pandemic, with nearly one-third noting a greater than
50% reduction in case volumes during the pandemic. In concert
with most reporting reduced non-MT urgent NI procedures and
a nearly unanimous cessation of non-urgent elective cases, over
two-
thirds of physicians noted dramatic reductions (>50%)
in NI procedural volume compared with pre-pandemic. These
findings add to existing reports that suggest decrements in procedural volumes for specific procedures, such as thrombectomy,7
but in contrast provide unique data from operators themselves
highlighting the widespread nature of the pandemic’s impact.
The neurological manifestations of COVID-19 are becoming
more clear,8 9 including ELVO in young COVID-
positive
patients.10 There are data suggesting that COVID-19 may induce
inflammation, hypoxia, and diffuse intravascular coagulation,
and may increase the risk of arterial thrombotic disease.11 12 Widespread proinflammatory cytokine responses may also contribute
to an increased risk of stroke,13 which was demonstrated in
about 3% of COVID-
positive patients in China.14 Paradoxically, many centers have noticed reduced MT procedural incidence, which have until recently been steadily increasing.15 16
Recent reports have corroborated the reduced MT volumes in
this study. In the state of Michigan, admissions for ischemic
stroke and MT procedures were significantly lower during the
month of March 2020 compared with immediately prior.17 A
multicenter US study similarly indicated a substantial reduction
in MT volumes during the pandemic compared with the year
prior with increases in onset-presentation times noted.18 This
decrease was further supported by a sharp decline in the number
of stroke imaging evaluations at the height of the pandemic.19
The present survey confirms that a reduction in urgent and
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emergent NI procedural volumes occurred despite most respondents reporting unchanged selection criteria for procedures. The
reason for lower procedural volumes remains a matter of investigation. Whether this represents a reduced incidence of stroke or
a reduction in stroke presentations for fear of COVID-19 exposure at hospitals and/or consequences of social distancing and
isolation is unknown. Future studies examining MT procedural
incidence and stroke admissions after the resumption of elective
cases and relaxing of social distancing measures will be necessary
to better understand this phenomenon.
Importantly, this survey suggests an overall low exposure rate
of NI physician and team members. Specifically, NI physician
and staff COVID-19 infections were rare, with under 10% of
respondents reporting a need to quarantine or a COVID-19
admission for members of the NI team. Transmission to healthcare workers in the Chinese epicenter was primarily related to
term exposure to positive
lack of appropriate PPE and long-
patients.20 Outside of Wuhan, transmission from patients to
healthcare workers appears to be relatively low21 22 except for
those positioned on the front lines in epicenters,23 although no
robust widespread studies have been published yet. While the
majority of respondents in this survey reported having examined or performed procedures on COVID-19-positive patients,
very few physicians reported having to self-quarantine or having
team members admitted with severe illness. The low number
of COVID-19-positive NI physicians is likely due, at least in
part, to preserved access to adequate PPE in the overwhelming
majority of centers, as indicated by survey responses. Additionally the rapid dissemination of society recommendations, such as
that of SNIS, may have played a role in educating and assisting
physicians in performing procedures with a safer workflow.
Finally, near-universal cessation of elective procedures during
the end of March and April likely helped to minimize unnecessary team member exposures. For respondents reporting the
need to isolate or that suffered actual infection it is not possible
to determine from our data whether the source of exposure is
the community or the practice environment.
The personal and professional consequences of the pandemic on
NI physician appear less uniform. A plurality of respondents indirelated stress
cated slight increases in work and personal/family-
during the pandemic months, yet a plurality reported no overall
change in burnout, and paradoxically 0ne-third or more of respondents actually reported reduced work or family stress. Recent surveys
of NI physicians and NI non-physician staff members demonstrated
self-reported burnout rates ranging between 50% and 60%.24 25 In
the present survey, about 60%–70% of respondents report either
slightly or greatly increased stress involving their career and their
personal and family life. However, nearly half of respondents suggest
no change or less career burnout compared with pre-pandemic.
Studies evaluating risk factors for psychological stress during the
pandemic have suggested more pronounced depression, anxiety,
and stress in healthcare workers that are single, less experienced,
female, and working on the frontline.26 In this study, females represented only a small minority of respondents and a low percentage
of physicians were allocated to frontline positions outside of their
usual scope of practice, which may partly explain discrepancies. An
additional factor may be the diminution in caseload, and therefore
reductions in direct work-
related pressures for physicians, with
increased family time now available. Notably, there was no link
between burnout and practicing in a pandemic epicenter or not.
The only factor significantly related to increased career and personal
stress in the present study was having a COVID-19-positive immediate family member, which was rare in the surveyed population
(5%). This finding highlights the opportunity for targeted burnout
930

support measures for practitioners that experience COVID-19 infection in family members in the future. Although many respondents
do report increased career stress and almost half suffered reduced
compensation, only a small percentage reported concerns regarding
employment sustainability.
The global COVID-19 pandemic is unprecedented within our
lifetimes. There is no time in recent history where non-
urgent
patient procedures or visits have been suspended. Consequently,
there are no validated instruments that have been developed for
understanding or analyzing the impact of the pandemic on healthcare delivery. This survey represents a novel attempt to study the
general effects of the pandemic specifically on the NI landscape,
surveying members of the three major societies (SNIS, SVIN, and
the AANS/CNS CV Section) for a unique scope. As expected, this
study confirms widespread disruption of NI practices with dramatic
reductions in case volumes and substantial perceived effects on MT
processes and quality of care. Surveys designed to address high-
priority issues in other medical specialties have unanimously demonstrated marked disruptions in clinical practice.27–30 Although the
present study did not specifically address the effects of COVID-19
on neurovascular research, a concomitant study has also revealed
widespread disruptions in aneurysm and stroke clinical trials due
to missed enrollments and protocol deviations from missed clinical
or imaging follow-up31 These broad vantage points are particularly
important given the widespread fears about resurgent infection,32 33
with the persistence of the virus in communities across the US. This
data helps inform current responses, but also future ones in the event
of subsequent pandemics.
There are several important limitations to this approach. As a
survey study, this study is subject to the inherent limitations of survey
methodology, including recall and selection bias. Many of the survey
responses were subjective in nature, for example severity of effect
on quality of care which may be interpreted differently among practitioners and is particularly subject to recall bias. However, many
responses were allowed to remain subjective in nature to encourage
broader physician engagement and completion of the survey instrument. A number of potentially important demographic or practice
specific questions, such as region, were not included in the survey
by the writing group to ensure anonymity of respondents. The
questions used were not previously validated and were designed
specifically for the NI physician population, which may limit their
generalizability to other specialties and may make comparison
with data from other surveys less valid. The relatively low rate of
physician response (approximately 15%) may be seen as a limitation. The reasons for this relatively low response rate are unclear,
but one possibility is the potential impact of pre-existing administrative and clinical burdens of maintaining NI services during the
COVID-19 pandemic. Response rates could arguably be improved
by performing the survey in the post-pandemic setting, however,
conducting the study in a delayed fashion also would likely introduce a more considerable effect of recall bias.

CONCLUSIONS

This is the first study to survey US neurointerventional physicians to understand the effects of the COVID-19 pandemic
on physician practices, case volumes, compensation, personal/
family stresses, and work-related burnout. Reduced MT procedural volumes were widely reported with over two-thirds of
physicians reporting dramatic reductions (>50%) in NI procedural volume compared with pre-pandemic. NI physician and
staff COVID-19 infections were quite rare, with under 10%
of respondents reporting a need to quarantine or a COVID-19
admission for members of their NI teams. A plurality of physicians reported increased occupational and personal stress.
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Future studies examining these factors following the resumption
of elective cases and relaxing of social distancing measures will
be necessary to better understand these phenomena.
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